Yavuz Anacak - Concepedia

Author

Yavuz Anacak

Ege University ORCID

Also Known As

Anacak Yavuz, Dimitris Visvikis, Ulkem Aydin, Y Anacak, Y. ANACAK, Y. Anacak, Yavuz ANACAK, Yavuz AnacaK, Yavuz Anacak

156

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Ege University Rambam Health Care Campus University Hospital of Lausanne Gdańsk Medical University Instituut Verbeeten

About

Yavuz Anacak is an author at Ege University specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	22	1.2K
2	Health Sciences	6	6	158
3	Social Sciences	1	1	16
4	Global Health	1	1	24
5	International Health	1	1	24

Yavuz Anacak

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Outcomes and patterns of failure in solitary plasmacytoma: A multicenter Rare Cancer Network study of 258 patients Mahmut Özsahin, Richard Tsang, Philip Poortmans, International Journal of Radiation OncologyBiologyPhysics MedicineSurgical PathologyPathologyOncologyRadiation Oncology	2005	274
Radiotherapy capacity in European countries: an analysis of the Directory of Radiotherapy Centres (DIRAC) database Eduardo Rosenblatt, J. Iżewska, Yavuz Anacak, The Lancet Oncology Adaptive RadiotherapyOncologyRadiation TherapyRadiotherapy CapacityEuropean Countries	2013	136
Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network Damien C. Weber, Yucai Wang, Robert C. Miller, Neuro-Oncology	2014	122
The Results of Surgery, With or Without Radiotherapy, for Primary Spinal Myxopapillary Ependymoma: A Retrospective Study From the Rare Cancer Network Alessia Pica, Robert C. Miller, S. Villà, International Journal of Radiation OncologyBiologyPhysics Retrospective StudySurgical OncologyRare Cancer NetworkMedicineSurgical Pathology	2009	114
Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: A Rare Cancer Network study Enis Özyar, Uğur Selek, Siddihartha Laskar, Radiotherapy and Oncology MedicinePediatric PatientsNasopharyngeal CancerPediatricsNon-metastatic Nasopharyngeal Carcinoma	2006	97
Is there an increased risk of spinal relapse in standard-risk medulloblastoma/primitive neuroectodermal tumor patients who receive only a reduced dose of craniospinal radiotherapy? CHILDS NERVOUS SYSTEM, vol.34, pp.1657-1662, 2018 (Link) Burcu Akıncı, Nazan Çetingül, Hamiyet Hekimci Özdemir, RUNA. Repositorio Institucional del Sergas (Servicio Gallego de Salud (SERGAS))	2018	95
The Essential Role of Radiotherapy in the Treatment of Merkel Cell Carcinoma: A Study From the Rare Cancer Network Pirus Ghadjar, Johannes H.A.M. Kaanders, P. Poortmans, International Journal of Radiation OncologyBiologyPhysics Rare Cancer NetworkEssential RoleRadiation TherapyMedicineBrachytherapy	2011	73
Primary Mucosa-Associated Lymphoid Tissue Lymphoma of the Salivary Glands: A Multicenter Rare Cancer Network Study Yavuz Anacak, Robert C. Miller, Nikos Constantinou, International Journal of Radiation OncologyBiologyPhysics Lymphoid NeoplasiaSurgical PathologyPathologySalivary GlandsLymphatic Disease	2010	67
Late radiation effects to the rectum and bladder in gynecologic cancer patients: the comparison of LENT/SOMA and RTOG/EORTC late-effects scoring systems Yavuz Anacak, Deniz Yalman, Zeynep Özsaran, International Journal of Radiation OncologyBiologyPhysics UrologyRadiation TherapyGenitourinary CancerMedicineLate Radiation Effects	2001	58
Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients. Senem Demirci, Erhan Eser, Zeynep Özsaran, PubMed	2011	51

Page 1